BIO-RAD LABORATORIES, INC. Quarterly Goodwill in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Bio Rad Laboratories, Inc. quarterly Goodwill history and growth rate from Q2 2010 to Q2 2024.
  • Bio Rad Laboratories, Inc. Goodwill for the quarter ending June 30, 2024 was $412M, a 0.15% increase year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $412M +$597K +0.15% Jun 30, 2024 10-Q 2024-08-02
Q1 2024 $413M +$5.06M +1.24% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $414M +$7.08M +1.74% Dec 31, 2023 10-Q 2024-08-02
Q3 2023 $407M +$7.36M +1.84% Sep 30, 2023 10-Q 2023-10-27
Q2 2023 $412M +$64.2M +18.5% Jun 30, 2023 10-Q 2023-08-04
Q1 2023 $408M +$62M +17.9% Mar 31, 2023 10-Q 2023-05-05
Q4 2022 $406M +$59.2M +17% Dec 31, 2022 10-K 2024-02-16
Q3 2022 $400M +$108M +36.9% Sep 30, 2022 10-Q 2022-10-28
Q2 2022 $347M +$55.4M +19% Jun 30, 2022 10-Q 2022-07-29
Q1 2022 $346M +$53.8M +18.4% Mar 31, 2022 10-Q 2022-04-29
Q4 2021 $347M +$55.4M +19% Dec 31, 2021 10-K 2024-02-16
Q3 2021 $292M $0 0% Sep 30, 2021 10-Q 2021-10-29
Q2 2021 $292M +$412K +0.14% Jun 30, 2021 10-Q 2021-07-30
Q1 2021 $292M +$27.8M +10.5% Mar 31, 2021 10-Q 2021-04-30
Q4 2020 $292M +$27.8M +10.5% Dec 31, 2020 10-K 2023-02-17
Q3 2020 $292M +$27.8M +10.5% Sep 30, 2020 10-Q 2020-10-30
Q2 2020 $292M +$56.1M +23.8% Jun 30, 2020 10-Q 2020-07-31
Q1 2020 $264M +$33.6M +14.6% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 $264M +$44.3M +20.2% Dec 31, 2019 10-K 2022-02-11
Q3 2019 $264M -$238M -47.4% Sep 30, 2019 10-Q 2019-11-01
Q2 2019 $235M -$265M -52.9% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $231M -$280M -54.8% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 $220M -$286M -56.6% Dec 31, 2018 10-K 2021-02-16
Q3 2018 $502M -$18.8M -3.61% Sep 30, 2018 10-Q 2018-11-05
Q2 2018 $500M -$30.3M -5.71% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 $510M -$5.83M -1.13% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 $506M +$29M +6.08% Dec 31, 2017 10-K 2020-03-02
Q3 2017 $521M +$14.1M +2.79% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 $530M +$25M +4.94% Jun 30, 2017 10-Q 2017-08-07
Q1 2017 $516M +$6.61M +1.3% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 $477M -$18.8M -3.79% Dec 31, 2016 10-K 2019-04-01
Q3 2016 $507M +$2.99M +0.59% Sep 30, 2016 10-Q 2016-11-02
Q2 2016 $505M -$8.77M -1.71% Jun 30, 2016 10-Q 2016-08-05
Q1 2016 $510M +$6.16M +1.22% Mar 31, 2016 10-Q 2016-05-06
Q4 2015 $496M -$4.5M -0.9% Dec 31, 2015 10-K 2018-04-16
Q3 2015 $504M -$9.87M -1.92% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 $514M -$21.1M -3.95% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 $503M -$17.1M -3.29% Mar 31, 2015 10-Q 2015-05-06
Q4 2014 $500M -$17.4M -3.36% Dec 31, 2014 10-K 2017-03-01
Q3 2014 $513M -$251K -0.05% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 $535M +$33.7M +6.73% Jun 30, 2014 10-Q 2014-08-06
Q1 2014 $521M +$18.4M +3.66% Mar 31, 2014 10-Q 2014-05-08
Q4 2013 $518M +$22.4M +4.52% Dec 31, 2013 10-K 2016-02-29
Q3 2013 $514M +$24.4M +4.98% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 $501M +$35.3M +7.58% Jun 30, 2013 10-Q 2013-08-08
Q1 2013 $502M +$22.1M +4.6% Mar 31, 2013 10-Q 2013-05-10
Q4 2012 $495M +$26.5M +5.65% Dec 31, 2012 10-K 2015-03-02
Q3 2012 $489M +$118M +31.8% Sep 30, 2012 10-Q 2012-11-08
Q2 2012 $466M +$73M +18.6% Jun 30, 2012 10-Q 2012-08-09
Q1 2012 $480M +$111M +30.1% Mar 31, 2012 10-Q 2012-05-10
Q4 2011 $469M +$105M +28.8% Dec 31, 2011 10-K 2014-03-18
Q3 2011 $371M +$19.4M +5.5% Sep 30, 2011 10-Q 2011-11-03
Q2 2011 $393M +$63.7M +19.4% Jun 30, 2011 10-Q 2011-08-04
Q1 2011 $369M Mar 31, 2011 10-Q 2011-05-06
Q4 2010 $364M Dec 31, 2010 10-K 2013-03-18
Q3 2010 $352M Sep 30, 2010 10-Q 2010-11-09
Q2 2010 $329M Jun 30, 2010 10-Q 2010-08-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.